Volume 23, Number 8—August 2017
Research Letter
Outcomes for 2 Children after Peripartum Acquisition of Zika Virus Infection, French Polynesia, 2013–2014
Marianne Besnard
, Timothée Dub, and Patrick Gérardin
, Timothée Dub, and Patrick Gérardin
Table
Follow-up of liver function test results associated with perinatal Zika virus infection in case-patient 2, French Polynesia, 2014*
| Date (postnatal day) | AST, U/L† | ALT, U/L‡ | GGT, U/L§ | Bilirubin, total/conjugate, mg/L¶ |
|---|---|---|---|---|
| Feb 4 (2) | 84 | 11 | 201 | 158 |
| Feb 6 (4) | 38 | 12 | 297 | 145 |
| Feb 10 (8) | 52 | 18 | 457 | 128/21 |
| Apr 8 (57) | 348 | 150 | 281 | 66/54 |
| Apr 16 (65) | 239 | 139 | 312 | 50/42 |
| Apr 30 (79) | 117 | 86 | 239 | 10 |
| May 13 (92) | 119 | 104 | 164 | 8 |
| Jun 17 (120) | 57 | 51 | 40 | 2 |
| Oct 25 (250) | 38 | 47 | 27 | 2 |
*Boldface indicates values out of reference range. ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase.
†Reference range 15–40 U/L.
‡Reference range 10–40 U/L.
§Reference range 2–34 U/L.
¶Reference range <14/<3 mg/L.
Page created: July 17, 2017
Page updated: July 17, 2017
Page reviewed: July 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.